Leflunomide Tablet
Product Images NDC 71335-2874

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Leflunomide (NDC 71335-2874). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image
Avet-logo (Avet Logo)
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
Change in Functional Ability Measure® is a tool used to evaluate improvement in functional ability, specifically in relation to the HAQ Disability Index. The measurement can be used to compare the effectiveness of different treatments such as Loflunomide, Methotrexate, Placebo, and Sulfasalazine.*
FDA Label Image

Label (Lbl713352874)

Label (Lbl713352874)
FDA Label Image

Structural-formula (Structural Formula)

Structural-formula (Structural Formula)
FDA Label Image

Teriflunomide-structural-formula. (Teriflunomide Structural Formula)

Teriflunomide-structural-formula. (Teriflunomide Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.